Health
Medical
Consulting

Syneos Health

$51.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.57 (1.11%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Syneos Health and other stocks, options, ETFs, and crypto commission-free!

About

Syneos Health, Inc. engages in the provision of product development and commercial solutions. It operates though the Clinical Solutions and Commercial Solutions segments. Read More The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC.

Employees
24,000
Headquarters
Raleigh, North Carolina
Founded
2010
Market Cap
5.31B
Price-Earnings Ratio
225.81
Dividend Yield
0.00
Average Volume
710.23K
High Today
$52.43
Low Today
$51.30
Open Price
$51.69
Volume
603.63K
52 Week High
$56.34
52 Week Low
$34.40

Collections

Health
Medical
Consulting
Business Services
2014 IPO
US
North America

News

MarketWatch12h

Syneos Health Inc. Cl A

Breaking Syneos Health Inc. revealed Wednesday afternoon that the Securities and Exchange Commission is investigating its accounting procedures. Trading was paused before the news was announced, and shares fell 23% in after-hours action after trading restarted. In a news release, the biopharmaceutical-services company said that it was delaying the release of its earnings results to allow additional time to review the company's internal controls over financial reporting after receiving notification of an in...

27
Associated PressMar 19

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc.

This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation. LOS ANGELES--(BUSINESS WIRE)--Mar 19, 2019--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the April 30, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Syne...

4
Guru FocusMar 19

RM LAW Announces Class Action Lawsuit Against Syneos Health, Inc.

BERWYN, Pa., March 19, 2019 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Syneos Health, Inc.

1

Earnings

$0.51
$0.66
$0.80
$0.95
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
$0.82 per share
Actual
$0.95 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.